Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Immunology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran; Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran; Student Research Committee, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Virus Res. 2020 Dec;290:198197. doi: 10.1016/j.virusres.2020.198197. Epub 2020 Oct 16.
The coronavirus disease-2019 (COVID-19) which caused by severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), is a pandemic threat to global public health. It has a wide spectrum of clinical manifestations from mild to critical illness, the most serious of which is the complications of acute respiratory distress syndrome (ARDS). SARS-CoV-2 infection appears mild in infants and children, however, in adults, it can lead to serious consequences. In this review, we highlighted the differences between the immune responses of the lung in children and adults, immune dysregulation and their possible role in clinical manifestations in COVID-19. There is a reduction in population of immunocompetent cells during aging and subsequently induced ineffective inflammation in the faces of some infections. Dysregulation in the immune system can lead to an unappropriated local and systemic immune responses and subsequently the rapid spread of the virus, leading to severe COVID-19 disease. Therefore, recognizing the differences in the immune responses of various hosts as well as to improve the immune system disorder should always be part of research and treatment protocols.
由严重急性呼吸综合征相关冠状病毒(SARS-CoV-2)引起的 2019 年冠状病毒病(COVID-19),是对全球公共卫生的一种大流行威胁。它具有从轻度到危重病的广泛临床表现,其中最严重的是急性呼吸窘迫综合征(ARDS)的并发症。SARS-CoV-2 感染在婴儿和儿童中表现为轻度,但在成年人中,它可能导致严重后果。在这篇综述中,我们强调了儿童和成人肺部免疫反应、免疫失调及其在 COVID-19 临床表现中的可能作用之间的差异。随着年龄的增长,免疫细胞数量减少,随后在某些感染中导致无效炎症。免疫系统失调可导致不适当的局部和全身免疫反应,从而导致病毒迅速传播,导致严重的 COVID-19 疾病。因此,认识到不同宿主的免疫反应差异,以及改善免疫系统紊乱,应该始终是研究和治疗方案的一部分。